Cookie Policy

Mereo BioPharma Group plc's website uses cookies. By continuing to browse you are agreeing to our use of cookies. Find out more about our Cookie Policy.

MREO: US$2.19
Mereo-Banner-Image.jpg

Working together to inspire, innovate and improve lives

See our latest news

News

26 Oct 2021 Mereo Receives U.S. Orphan Drug Designation for alvelestat in Treatment of AATD
13 Oct 2021 Mereo BioPharma, OIFE and OIF announce completion of the IMPACT Survey enrollment
1 Oct 2021 Mereo BioPharma and Ultragenyx Present Data from the Phase 2b ASTEROID Study of UX143 (setrusumab) in Osteogenesis Imperfecta (OI) at the American Society for Bone and Mineral Research (ASBMR) 2021 Annual Meeting
Press Releases

View our latest Corporate Presentation

section-img.jpg
7 OCT 2021 CORPORATE PRESENTATION
30 SEP 2021 Mereo to Participate at Cantor Fitzgerald Virtual Global Healthcare Conference: September 30, 2021 at 9:30am ET View webcast
profile-img.jpg
quote.svg

We continue to make strong progress in development of our product portfolio, in the hope of providing better treatment options for patients with life limiting oncology and rare diseases

Denise Scots-Knight, CEO Our Mission